2.4 semaglutide to tirzepatide (MOUNJARO, SEJARO) is a new class of medicine for the treatment of obesity and type 2 diabetes. This medicine is more advanced than (Ozempic and Semavic). It is a dual Troubling Findings in Study of

Observed side effects in research settings are generally mild and may include temporary nausea-related observations, flushing-related observations, headache-related observations, fatigue-related observations, administration-site irritation, pigmentation variability, pigmentation variability involving freckles or moles, and temporary appetite-related response variability depending on research amount, UV exposure, administration frequency, skin type, and individual physiological sensitivity

Demarquoy J

Alcohol is not off limits, but it hits harder because your stomach empties more slowly

If you experience any suspected side effects from using Victoza, you can report these through the Yellow Card Scheme at yellowcard.mhra.gov.uk or via the Yellow Card app

We do not provide products to patients and do not make any claims regarding medical use

11, 2012, nutritionj.biomedcentral.com/articles/10.1186/1475-2891-11-105